Trinity Biotech reported $100.49M in Current Liabilities for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Abbott ABT:US $ 12647M 458M
Bayer BAYN:GR € 31019M 1616M
Bio Rad Laboratories BIO:US $ 648.33M 32.61M
Cytori Therapeutics CYTX:US $ 4.92M 0.95M
Edap Tms EDAP:US $ 16.22M 1.74M
Johnson & Johnson JNJ:US $ 43390M 1836M
Mesa Laboratories MLAB:US $ 48.06M 1.28M
Orasure Technologies OSUR:US $ 55.59M 12.48M
Siemens SIE:GR € 42684M 1991M
Sientra SIEN:US $ 84.65M 4.63M
Surmodics SRDX:US $ 28.37M 2.73M
Thermo Fisher Scientific TMO:US $ 12070M 1366M
Tosoh 4042:JP Y 269878M 17466M
Veracyte VCYT:US $ 62.54M 1.61M